Bio-Rad Laboratories Inc. Cl A | Mutual Funds
Mutual Funds that own Bio-Rad Laboratories Inc. Cl A
Eaton Vance SMID Cap Portfolio
1,231,302
4.98%
0
3.08%
04/30/2018
iShares Core S&P Mid Cap ETF
554,734
2.24%
448
0.36%
09/06/2018
Vanguard Small Cap Index Fund
528,309
2.14%
7,004
0.18%
07/31/2018
Vanguard Total Stock Market Index Fund
526,462
2.13%
2,928
0.02%
07/31/2018
Vanguard Small Cap Growth Index Fund
301,008
1.22%
3,601
0.38%
07/31/2018
Vanguard Extended Market Index Fund
268,534
1.09%
5,000
0.12%
07/31/2018
SPDR S&P Mid Cap 400 ETF Trust
231,412
0.94%
0
0.36%
09/05/2018
Polar Capital Funds Plc - Healthcare Opportunities Fund
185,000
0.75%
0
3.44%
07/31/2018
iShares S&P Mid Cap 400 Growth ETF
175,848
0.71%
0
0.69%
09/06/2018
Government Pension Fund - Global (The)
174,272
0.71%
30,434
0.01%
12/31/2017
| Address |
1000 Alfred Nobel Drive
Hercules California 94547
United States
|
|
Employees
|
- |
| Website |
http://www.bio-rad.com |
| Updated |
07/08/2019 |
| Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through Life Sciences and Clinical Diagnostics segments. The Life Science segment develops, manufactures and markets reagents, apparatus, and laboratory instruments. |
